PET/CT finding of cardiac sarcoidosis

PET/CT finding of cardiac sarcoidosis - PET/CT finding of cardiac sarcoidosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004267

Enrollment

Registered

2010-10-01

Start date

2010-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcoidosis

Interventions

Give heparin Na before 18F-FDG PET/CT in the diagnosis of cardial sarcoidosis.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with histopathological and/or clinical diagnosis of sarcoidosis. 2. Informed consent

Exclusion criteria

Exclusion criteria: 1.Serious concomitant medical illness 2.Obvious bleeding tendency 3.Patients with gastrointestinal ulcer 4.Patients with heparin Na allegy

Design outcomes

Primary

Measure	Time frame
uptake on 18F-FDG PET/CT for cardiac muscle	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026